WO1999022005A3 - Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor - Google Patents
Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor Download PDFInfo
- Publication number
- WO1999022005A3 WO1999022005A3 PCT/US1998/022597 US9822597W WO9922005A3 WO 1999022005 A3 WO1999022005 A3 WO 1999022005A3 US 9822597 W US9822597 W US 9822597W WO 9922005 A3 WO9922005 A3 WO 9922005A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glucosaminyl
- heparan sulfate
- sulfotransferases
- uses therefor
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU11997/99A AU1199799A (en) | 1997-10-24 | 1998-10-23 | Heparan sulfate d-glucosaminyl 3-(o)-sulfotransferases, an uses therefor |
US09/557,262 US6861254B1 (en) | 1997-10-24 | 2000-04-24 | Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6276297P | 1997-10-24 | 1997-10-24 | |
US60/062,762 | 1997-10-24 | ||
US6543797P | 1997-10-31 | 1997-10-31 | |
US60/065,437 | 1997-10-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/557,262 Continuation US6861254B1 (en) | 1997-10-24 | 2000-04-24 | Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999022005A2 WO1999022005A2 (en) | 1999-05-06 |
WO1999022005A3 true WO1999022005A3 (en) | 1999-10-07 |
WO1999022005B1 WO1999022005B1 (en) | 1999-11-11 |
Family
ID=26742665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/022597 WO1999022005A2 (en) | 1997-10-24 | 1998-10-23 | Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1199799A (en) |
WO (1) | WO1999022005A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013910A2 (en) * | 1999-08-25 | 2001-03-01 | Massachusetts Institute Of Technology | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
US6977248B1 (en) * | 1999-08-25 | 2005-12-20 | Massachusetts Institute Of Technology | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
US6420150B1 (en) * | 2000-11-27 | 2002-07-16 | Pe Corporation (Ny) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
GB0111637D0 (en) * | 2001-05-12 | 2001-07-04 | Astrazeneca Ab | Methods |
CA2458182A1 (en) * | 2001-08-23 | 2003-03-06 | Sumitomo Chemical Company, Limited | Method for assessing cancerous state of mammal-derived specimen |
AU2003247808A1 (en) * | 2002-07-05 | 2004-01-23 | Anders Malmstrom | Purified and isolated heparan sulfate 3-o-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same |
US7166763B2 (en) * | 2003-02-10 | 2007-01-23 | Trustees Of Dartmouth College | Mouse model of myxomatous valvular disease |
WO2023118313A1 (en) * | 2021-12-21 | 2023-06-29 | University Of Copenhagen | Improved heparan sulfate and methods of making the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025659A1 (en) * | 1992-06-16 | 1993-12-23 | University Of Massachusetts Medical Center | Glycosaminoglycan specific sulfotransferases |
GB2295012A (en) * | 1994-10-29 | 1996-05-15 | Cancer Res Campaign Tech | Sequence analysis of polysaccharides with exoglycosidases, following partial depolymerisation |
-
1998
- 1998-10-23 AU AU11997/99A patent/AU1199799A/en not_active Abandoned
- 1998-10-23 WO PCT/US1998/022597 patent/WO1999022005A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025659A1 (en) * | 1992-06-16 | 1993-12-23 | University Of Massachusetts Medical Center | Glycosaminoglycan specific sulfotransferases |
GB2295012A (en) * | 1994-10-29 | 1996-05-15 | Cancer Res Campaign Tech | Sequence analysis of polysaccharides with exoglycosidases, following partial depolymerisation |
Non-Patent Citations (13)
Title |
---|
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002106186, Database accession no. F07258 * |
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002106187, Database accession no. W89350 * |
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002106188, Database accession no. N71828 * |
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002106189, Database accession no. T75445 * |
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002106190, Database accession no. F13088 * |
EMEST11 DATABASE Accession number AA460705 13-JUN-1997 (Rel. 52, Created) Hillier L. et al. * |
EMEST18 DATABASE Accession number AA407647 04-MAY-1997 (Rel. 51, Created) Ko M.S.H. et al. * |
EMEST19 DATABASE Accession number AA041885 05-SEP-1996 (Rel. 49, Created) glycosaminoglycan N-acetylglucosaminyl N-deacetylase Marra M. et al. * |
ERIKSSON I ET AL: "cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin.", J BIOL CHEM, APR 8 1994, 269 (14) P10438-43, UNITED STATES, XP002094359 * |
LIU J ET AL: "Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase.", J BIOL CHEM, OCT 25 1996, 271 (43) P27072-82, UNITED STATES, XP002094357 * |
SHWORAK NW ET AL: "Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool.", J BIOL CHEM, OCT 25 1996, 271 (43) P27063-71, UNITED STATES, XP002094360 * |
SHWORAK NW ET AL: "Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase.", J BIOL CHEM, OCT 31 1997, 272 (44) P28008-19, UNITED STATES, XP002094361 * |
SHWORAK, NICHOLAS W. (1) ET AL: "Control of the synthesis of anticoagulant heparan sulfate: Molecular cloning and expression of the rate limiting enzyme, 3 - O - sulfotransferase.", CIRCULATION, (10/21/97) VOL. 96, NO. 8 SUPPL., PP. I412. MEETING INFO.: 70TH SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION ORLANDO, FLORIDA, USA NOVEMBER 9-12, 1997 ABSTRACT 2300, XP002094358 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999022005A2 (en) | 1999-05-06 |
AU1199799A (en) | 1999-05-17 |
WO1999022005B1 (en) | 1999-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69534778D1 (en) | Cathepsin-02-protease | |
AU3199595A (en) | Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same | |
AU4008495A (en) | Tcl-1 gene and protein and related methods and compositions | |
ZA986051B (en) | Isolated mammalian membrane protein genes related reagents | |
AU1686395A (en) | (deltex) proteins, nucleic acids, and antibodies, and related methods and compositions | |
WO1999020747A3 (en) | HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS | |
WO1996027665A3 (en) | Neuron-restrictive silencer factor proteins | |
CA2336261A1 (en) | Cyclin e2 genes and proteins | |
AU3866197A (en) | Novel DNA and process for preparing protein using the DNA | |
WO1999022005A3 (en) | Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor | |
MX9806041A (en) | PURIFIED SR-p70 PROTEIN. | |
AU1620099A (en) | Ubiquitin-like conjugating protein | |
WO2000018909A3 (en) | NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) | |
AU3711597A (en) | A novel galanin receptor | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
AU1137699A (en) | Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor | |
AU3063699A (en) | Isolated mammalian membrane protein genes and related reagents | |
WO1998017827A3 (en) | Compositions and methods using eukaryotic rad52 | |
AU6260796A (en) | Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof | |
WO2000029564A3 (en) | Human glycine transporter type 2 | |
AU1525499A (en) | Ikap proteins, nucleic acids and methods | |
EP0846165A4 (en) | Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof | |
AU6275098A (en) | Novel h-rev 107-like protein | |
AU5545896A (en) | H. Influenzae HxuB and HxuC genes, proteins and methods of use | |
AU7478098A (en) | Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |